Diabetes. Add-on to metformin in T2DM--linagliptin or glimepiride?

Mikkel Christensen; Filip K Knop

doi:10.1038/nrendo.2012.163

Diabetes. Add-on to metformin in T2DM--linagliptin or glimepiride?

2 Citations (Scopus)

Original language	English
Journal	Nature Reviews Endocrinology
Volume	8
Issue number	10
Pages (from-to)	576-8
Number of pages	3
ISSN	1759-5029
DOIs	https://doi.org/10.1038/nrendo.2012.163
Publication status	Published - Oct 2012

Keywords

Diabetes Mellitus, Type 2
Dipeptidyl-Peptidase IV Inhibitors
Humans
Hypoglycemic Agents
Metformin
Purines
Quinazolines
Sulfonylurea Compounds

Access to Document

10.1038/nrendo.2012.163

Cite this

@article{d04c71215b094dd0ab85890730f85fe4,

title = "Diabetes. Add-on to metformin in T2DM--linagliptin or glimepiride?",

keywords = "Diabetes Mellitus, Type 2, Dipeptidyl-Peptidase IV Inhibitors, Humans, Hypoglycemic Agents, Metformin, Purines, Quinazolines, Sulfonylurea Compounds",

author = "Mikkel Christensen and Knop, \{Filip K\}",

year = "2012",

month = oct,

doi = "10.1038/nrendo.2012.163",

language = "English",

volume = "8",

pages = "576--8",

journal = "Nature Reviews Endocrinology",

issn = "1759-5029",